Invitation for 2027 Biomedical Pitch Competition
Connecting Global Innovation with Strategic Capital
You are cordially invited to participate in the 2027 Biomedical Pitch Competition. This premier event serves as a bridge between high-potential biomedical start-ups and a global network of investors and accelerator resources. We welcome applications from all biomedical startups, ranging from concept-stage to pre-IPO.
Application Deadline: February 28, 2027
Target Sectors: Biotechnology · Pharmaceuticals · Medical Devices · AI + Digital Health · Medical Diagnosis · Aesthetic Medicine · Life Science Tools
Why Participate?
Participating firms gain access to an unparalleled ecosystem of support and funding:
- Proven Funding Success: Over $300 million has been raised by participant firms in the last four years.
- Direct Investor Access: Engage with 200+ Angel investors, VC funds, and MNCs for potential equity investment.
- Elite Judging Panel: Present your technology to senior leaders from top-tier VCs and Multi-National Corporations.
- Strategic Opportunities: Secure fundraising, License-Out agreements, or NewCo opportunities.
- Strategic Partnerships: Network with serial entrepreneurs, corporate executives, and specialized attorneys.
- Global Exposure: Benefit from media coverage through partner networks with over 20,000+ views.
A Track Record of Impact
2026 Pitch Competition Highlights
- Byterna Therapeutics raised funding successfully
- XTOP claimed a research collaboration deal with Daiichi Sankyo
- One finalist is in the final stage of closing a funding round
- A 2023 candidate company landed in Asia
2025 Pitch Competition Highlights
- Epigenic raised $60 million successfully
- Groovy raised funding
2024 Pitch Competition Highlights
- Rapafusyn raised $44 million successfully in the USA
- Agilis secured $10 million from a Singapore family office
- GV20 secured funding of over $30 million
- Affinity secured $55 million in funding
- ImmViral filed for IPO
2023 Pitch Competition Highlights
- Myrobalan raised $24 million within 5 months after participating
- Two startups raised $2M and $2M separately
- At least one startup landed in Asia
2022 Pitch Competition Highlights
- Amytrx raised $18 million
- ARIZ Precision Medicine raised $3 million
- Biostage raised $5 million
- At least two startups landed in Asia
Timeline
| Stage | Date |
|---|---|
| Registration Deadline | February 28, 2027 |
| Preliminary Pitches | March 2027 |
| Semi-Final Pitches | March 2027 |
| Final Contest (Boston, USA) | May 2027 |
Registration
Option 1 (preferred): Google Form https://forms.gle/uZbefcLhdNXQC2Ek8
Option 2: Jinshu Ju Form https://3nv6qhsf.jsjform.com/f/dFKDMv
Eligibility & Requirements
- Legal Compliance: Startups must comply with relevant laws in the U.S. and their residing countries.
- Integrity: Participants are responsible for the accuracy of all registration information.
- Innovation: Products/ideas must be original, innovative, and possess market value.
- Focus: Entities must operate within the biomedical industry or related sub-industries.
- Inclusivity: No nationality restrictions. We welcome entities seeking either Chinese or U.S. funding.
Judges (TBD)
- Hong Kong Science and Technology Parks Corporation (HKSTP)
- Northern Light Venture Capital
- TCG Crossover
- Chugai Venture
- Kendall Capital Partners (KCP)
- PagodaTree Partners
- Eisai Innovation Inc.
Partners
Harvard Life Lab · Harvard Innovation Labs · Harvard Wyss Institute · Harvard Medical School CSSA · Ohio State University College of Pharmacy Innovation Center · Pittsburg University Healthcare Incubator · Stanford Healthcare Innovation Lab · Nest.Bio · Netherlands Innovation Center (NIC) · Frees Fund · JJLake Asia Future Innovation Challenger · Dane Capital · Aquillius · Simcere Therapeutical · Blue Ocean Capital Group · DukeCEO · Penn Quakers Venture Club · Fish & Richardson · InnoStar · Porton · Yale Venture Club · The Hopkins Club for Innovation and Entrepreneurship · Asia America Innovation Alliance (AAIA) · GeneOnline · LEAP · HUST Boston Alumni Association · YuanBio Venture Capital · PagodaTree Partners · AbbVie Ventures · F Prime · Amgen Ventures · Greenberg Traurig · Baker McKenzie · The Chinese Antibody Society (CAS) · Berkeley QB3 · Startup Boston · Biolink · BioKatalyst · VIVA · Medicilon · ATLATL · Slush China · Association d'Incubateur Franco-Chinois (AIFC) · Brandeis Impact · Chinese Entrepreneurs Organization · CuBio Innovation Center · Eisai Innovation Inc · Regent Advisors · Enterprise Singapore · Massachusetts Biomedical Initiatives (MBI) · K2 Venture Partners · Singapore Economic Development Board (EDB) · Saudi Arabia NEOM Biotech Investment · P4 Precision Medicine Accelerator (UK)
Contact: info@bcicglobal.org · www.bcicglobal.org · WeChat: bcicglobal